Topics

Let's Not Minimize the Impact of Progression-Free Survival

12:20 EST 8 Nov 2019 | Medscape

The excitement of KEYNOTE-001, presented at this year's ASCO, was imperceptible in the published article. Dr Mark Kris says we shouldn't miss the real message: Patients were disease free at 5 years.
Medscape Oncology

Original Article: Let's Not Minimize the Impact of Progression-Free Survival

NEXT ARTICLE

More From BioPortfolio on "Let's Not Minimize the Impact of Progression-Free Survival"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...